Delivery Order SPE2DR25D2104-SPE2DR26F3PXU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,441.71 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within...
- The Defense Logistics Agency (DLA) awarded a $24,916.23 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency awarded a $2,869.43 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on October 31, 2025, with completion targeted for November 3, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $3,884.63 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on November 13, 2025, with completion scheduled for November 14, 2025. This non-competitive delivery order represents a firm fixed price transaction sourced from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,320.83 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on October 24, 2025, with completion targeted for October 27, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, PA. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,373.47 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 9, 2025, with a completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary...
- The Defense Logistics Agency awarded a $21,047.54 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packages) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a $13,614.27 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on December 10, 2025, with completion scheduled for December 11, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The award will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,214.37 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8 count) on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $23,382.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was fulfilled...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PXUDelivery Order
The Defense Logistics Agency (DLA) awarded a $15,945.04 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packages) on November 25, 2025, with completion scheduled for November 26, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. NURTEC ODT is a preventive treatment for migraine headaches, reflecting the pharmaceutical distributor's role in supplying specialized neurological medications to support military and federal healthcare systems. This delivery order exemplifies AmerisourceBergen's established capability as a critical vendor within the federal medical supply chain, leveraging its comprehensive IDC vehicle to fulfill dynamic pharmaceutical procurement needs across defense healthcare programs. As a major pharmaceutical distributor serving the Defense Health Agency and other federal healthcare entities, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.9k | 11/24/25 |